Application of Adenosine 5'-Triphosphate (ATP) Infusions in Palliative Home Care
Phase 3
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Cancer, Palliative Care, Survival, Quality of Life
Both
Cancer, Palliative Care, Survival, Quality of Life
Trial Information
Application of Adenosine 5'-Triphosphate (ATP) Infusions in Palliative Home Care
Inclusion Criteria:
- cytologically or histologically confirmed cancer
- medical treatment options restricted to supportive care
- a life expectancy < 6 months
- World Health Organization (WHO) performance status 1 or 2
- suffering from at least one of the following complaints: fatigue, weight loss > 5%
over the last 6 months, or anorexia
Exclusion Criteria:
- symptomatic angina pectoris
- symptomatic heart failure
- any form of atrioventricular (AV) block (assessed by electrocardiogram)
- life expectancy < 4 weeks
- concurrent palliative chemotherapy
- cognitive dysfunction, and other diseases hampering adequate follow up
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Survival Physical restriction Fatigue Quality of life
Outcome Time Frame:
0-8 weeks
Principal Investigator
P.C. Dagnelie, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Maastricht University - Department of Epidemiology
Authority:
Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)
Study ID:
MEC 01-092.3
NCT ID:
NCT00565188
Start Date:
March 2002
Completion Date:
October 2006
Related Keywords:
- Cancer
- Palliative Care
- Survival
- Quality of Life
Name | Location |
|---|
